References
- Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–S119
- Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med. 2004;351(13):1296–1305
- Goodman WG, London G, Amann K, et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004;43(3):572–579
- Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest. 2008;118(12):3820–3828
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281
- Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(16):1730–1737
- Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–511
- Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25OHD and risk of myocardial infarction in men: A prospective study. Arch Intern Med. 2008;168:1174–1180
- Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340–1349
- Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older US adults. J Am Geriatr Soc. 2009;57(9):1595–1603
- Jones G. Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs. Semin Dial. 2010;23(3):239–243
- Dusilová-Sulková S, Safránek R, Vávrová J, Horáček J, Pavlíková L, Palička V. Low-dose cholecalciferol supplementation and dual vitamin D therapy in hemodialysis patients. Int Urol Nephrol. 2015;47(1):169–176
- Bodyak N, Ayus JC, Achinger S, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA. 2007;104(43):16810–16815
- Simpson RU, Hershey SH, Nibbelink KA. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol. 2007;103(3-5):521–524
- Przybylski R, McCune S, Hollis B, Simpson RU. Vitamin D deficiency in the spontaneously hypertensive heart failure (SHHF) prone rat. Nutr Metab Cardiovasc Dis. 2010;20(9):641–646
- Bae S, Yalamarti B, Ke Q, et al. Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. Cardiovasc Res. 2011;91(4):632–639
- Matias PJ, Jorge C, Ferreira C, et al. Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol. 2010;5(5):905–911
- Bucharles S, Barberato SH, Stinghen AE, et al. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism. J Ren Nutr. 2012;22(2):284–291
- Mose FH, Vase H, Larsen T, et al. Cardiovascular effects of cholecalciferol treatment in dialysis patients – A randomized controlled trial. BMC Nephrol. 2014;15:50
- Garcia-Lopes MG, Pillar R, Kamimura MA, et al. Cholecalciferol supplementation in chronic kidney disease: Restoration of vitamin D status and impact on parathyroid hormone. Ann Nutr Metab. 2012;61(1):74–82
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD–MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD). Kidney Int Suppl. 2009;(113):S1–S130
- Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358–367
- Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–458
- Adragao T, Pires A, Lucas C, et al. A simple vascular calcification score predicts cardiovascular risk in hemodialysis patients. Nephrol Dial Transplant. 2004;19(6):1480–1488
- Miller JT, O'Rourke RA, Crawford MH. Left atrial enlargement: An early sign of hypertensive heart disease. Am Heart J. 1988;116(4):1048–1051
- Ristow B, Ali S, Whooley MA, Schiller NB. Usefulness of left atrial volüme index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study). Am J Cardiol. 2008;102(1):70–76
- Tamez H, Zoccali C, Packham D, et al. Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J. 2012;164(6):902–909.e2
- Cardús A, Panizo S, Parisi E, Fernandez E, Valdivielso JM. Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res. 2007;22(6):860–866
- García-Canton C, Bosch E, Ramírez A, et al. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant. 2011;26(7):2250–2256
- Delanaye P, Weekers L, Warling X, et al. Cholecalciferol in hemodialysis patients: A randomized, double-blind, proof-of-concept and safety study. Nephrol Dial Transplant. 2013;28(7):1779–1786
- Matias PJ, Ferreira C, Jorge C, et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in hemodialysis patients. Nephrol Dial Transplant. 2009;24(2):611–618
- Jean G, Terrat JC, Vanel T, et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in hemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant. 2008;23(11):3670–3676
- Aguilera A, Sánchez-Tomero JA, Bajo MA, et al. Malnutrition–inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients. Adv Perit Dial. 2003;19:240–245
- Demir M, Kucuk A, Sezer MT, Altuntas A, Kaya S. Malnutrition–inflammation score and endothelial dysfunction in hemodialysis patients. J Ren Nutr. 2010;20(6):377–383